会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 이미다졸린 고리가 치환된 카바페넴 유도체
    • 用咪唑啉环取代的卡宾芬衍生物
    • KR1020010077072A
    • 2001-08-17
    • KR1020000004630
    • 2000-01-31
    • 한국과학기술연구원
    • 조정혁오창현이기수이창식이인규이숙자
    • C07D477/20
    • PURPOSE: Provided are novel 1-β-methylcarbapenem derivatives substituted by pyrrolidine containing imidazoline ring which are strong antibiotics against resistant bacteria. CONSTITUTION: The compound is represented by chemical formula 1, where R is C1-6 low alkyl, aryl and benzyl group which are substituted by one or more groups from hydrogen, hydroxy, amine, sulfonyl and aminosulfonyl group. The process of preparing the compound consists of: converting diazoazetidione compound, chemical formula 2, to two ring keto ester under rhodium acetate catalyst and reacting at 0-5deg.C with diphenylchlorophosphate under base such as diisopropylethylamine; reacting the resultant with thiol derivative of chemical formula 3, and eliminating allyl group from the product by reacting with tributyltinhydride under tetrakisphosphine palladium(0) catalyst at room temp. for 2 hours. After reactions, distilled water is added to extract the water layer and it is freeze dried to get the final compound.
    • 目的:提供由吡咯烷咪唑啉环取代的新颖的1-β-甲基碳青霉烯衍生物,它们是抗性细菌的强抗生素。 构成:该化合物由化学式1表示,其中R为被氢,羟基,胺,磺酰基和氨基磺酰基中的一个或多个基团取代的C 1-6低级烷基,芳基和苄基。 制备化合物的方法包括:在乙酸铑催化剂下将二唑并二酮化合物,化学式2转化为两个环酮酯,并在0-5℃与二氯丙酸二苯酯在二异丙基乙胺的碱下反应; 使所得物与化学式3的硫醇衍生物反应,并在室温下在四膦合钯(0)催化剂下与三丁基氢化锡反应从产物中除去烯丙基。 2小时。 反应后,加入蒸馏水提取水层,冷冻干燥,得到最终的化合物。
    • 4. 发明公开
    • N₂S₂리간드가 결합된 테트라벤아진 유도체 및 그의 제조방법
    • 用N2S2配体连接的四氢萘衍生物及其制备方法
    • KR1020000051077A
    • 2000-08-16
    • KR1019990001315
    • 1999-01-18
    • 한국과학기술연구원
    • 조정혁오창현이기수이창식이명철정준기이동수정재민
    • C07D221/06
    • PURPOSE: Tetrabenazine derivatives attached with an N2S2 ligand useful as an imaging compound for endoplasmic reticulum transporter or reuptake site and preparing process thereof are provided which label a technetium having the radiochemically optimum physical conditions. CONSTITUTION: A tetrabenazine derivatives represented by the formula (1) have the advantage of labelling a technetium having the optimum physical conditions such as manufacturing easiness, half-life period, radioactive strength and purchase easiness. Also the compound can image an endoplasmic reticulum transporter as a marker of Parkinson's disease by attaching an N2S2 ligand to tetrabenazine to introduce technetium into tetrabenazine and providing an imaging compound of the transporter as a radioligand.
    • 目的:提供与用作内质网转运体或再摄取位点的成像化合物的N2S2配体连接的丁苯那嗪衍生物及其制备方法,其标记具有放射化学最佳物理条件的锝。 构成:由式(1)表示的丁苯那嗪衍生物具有标记具有制造容易性,半衰期,放射性强度和购买容易性等最佳物理条件的锝的优点。 此外,化合物可以通过将N2S2配体连接到丁苯那嗪来将内质网转运蛋白图像化为帕金森病的标记物,以将锝引入到丁苯那嗪中,并将转运体的成像化合物作为放射性配体提供。
    • 6. 发明公开
    • 메틸렌디포스폰산의제조방법
    • 甲基二磷酸的制备方法
    • KR1020000020033A
    • 2000-04-15
    • KR1019980038443
    • 1998-09-17
    • 한국과학기술연구원
    • 조정혁오창현이기수이창식이명철정준기이동수정재민
    • C07F9/00C07F9/38
    • PURPOSE: A preparation method of methylene diphosphonic acid by using diidomethane having a higher boiling point than reaction temperature is provided which produces the title compound in high yield, improves high productivity and is very economic by reusing trialkylphosphate as a starting material. CONSTITUTION: A process is disclosed for preparing methylene diphosphonic acid(1) which comprises: (a)preparing tetralkylmethylenediphosphonic acid ester(4) by reacting trialkyl phosphate(2) with diiodomethane(3); (b)separating the compound(4) from the reactant by removing alkyl iodine; (c)recovering excess trialkylphosphate by distillation at 180°C and recycling to the process(a); (d)removing alkyl groups by thermal-cracking the ester at 200-210°C and recrystallizing. In formula, R is allyl, isopropyl, t-butyl, isobutyl. The compound is useful as raw material of radioactive pharmaceuticals for diagnosis.
    • 目的:提供通过使用沸点比反应温度高的二甲基亚甲基二膦酸的制备方法,其以高产率产生标题化合物,提高高生产率,并且通过重复使用三烷基磷酸酯作为起始原料是非常经济的。 公开:制备亚甲基二膦酸(1)的方法,其包括:(a)通过使三烷基磷酸酯(2)与二碘甲烷(3)反应制备四烷基亚甲基二膦酸酯(4); (b)通过除去烷基碘将化合物(4)与反应物分离; (c)通过在180℃下蒸馏回收过量的三烷基磷酸酯并再循环至方法(a); (d)通过在200-210℃下热裂解酯并重结晶来除去烷基。 在式中,R是烯丙基,异丙基,叔丁基,异丁基。 该化合物可用作放射性药物的诊断原料。